{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-258013","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2023-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.349047+00:00","generated_at":"2026-06-09T21:41:19.963197+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Elevance Health Q3 adj. EPS $8.99, revenue $42.5B (+7.2%); raises FY23 guidance","bullets":["GAAP EPS $5.45 includes $3.54/share net negative items; adjusted EPS $8.99.","Operating revenue $42.5B, up 7.2% YoY; benefit expense ratio improved 40 bps to 86.8%.","Medical membership 47.3M, down 664K sequentially due to Medicaid redeterminations and competitor entry.","Company raises FY2023 guidance: GAAP EPS >$26.40, adjusted EPS >$33.00.","Q3 includes $697M business optimization charge; operating cash flow $2.6B, 2.0x net income."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-258013","json":"https://secwatch.observer/filing/0001193125-23-258013.json","markdown":"https://secwatch.observer/filing/0001193125-23-258013.md","text":"https://secwatch.observer/filing/0001193125-23-258013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523258013/0001193125-23-258013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523258013/d568311d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T21:41:19.963197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11b6cb5b007dbc0dd873749c2e06494ff61e32bd","claim":"Elevance Health, Inc. reported the quarter ended September 30, 2023 results: revenue $42.5 billion, net income $5.45 per share, EPS $5.45 per share. Guidance raised.","evidence_excerpt":"third quarter of 2023, medical membership decreased by 664 thousand driven by attrition in Medicaid due to the aforementioned dynamics. Operating Revenue: Operating revenue was $42.5 billion in the third quarter of 2023, an increase of $2.9 billion, or 7.2 percent year-over-year. The increase was primarily driven by higher premium revenue in our Health Benefits","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523258013/0001193125-23-258013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$42.5 billion"},{"label":"Net income","value":"$5.45 per share"},{"label":"EPS","value":"$5.45 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}